Follow The Filings

NYT New York Times

New York Times earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.67 — —
Rev $766.9M — —

Insider trades

Open-market buys and sales by NYT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NYT insider trades
  • None no insider bought on the open market
  • $9.8M sold by 7 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Jacqueline M Welch EVP and CHRO
    Sale
    $297K 4,000 shares at $74.14 14% of stake
    Traded Jun 3 Filed Jun 5
  2. William Bardeen CFO
    Sale
    $321K 4,121 shares at $77.85 22% of stake
    Traded May 12 Filed May 14
  3. Levien Meredith A. Kopit CEO
    Sale
    $761K 9,750 shares at $78.00 4.3% of stake
    Traded May 12 Filed May 14
  4. David S. Perpich Director
    Sale
    $694K 9,000 shares at $77.06 24% of stake
    Traded May 11 Filed May 12
  5. William Bardeen CFO
    Sale
    $1M 13,000 shares at $79.56 41% of stake
    Traded Mar 3 Filed Mar 5
  6. Levien Meredith A. Kopit CEO
    Sale
    $4.1M 51,949 shares at $79.70 19% of stake
    Traded Mar 3 Filed Mar 5
  7. Arthur G. Sulzberger Chair
    Sale
    $1M 13,000 shares at $79.95 7% of stake
    Traded Mar 3 Filed Mar 5
  8. Diane Brayton EVP, Chief Legal Officer
    Sale
    $354K 4,600 shares at $77.03 14% of stake
    Traded Feb 20 Filed Feb 24
  9. R Anthony Benten SVP, Treasurer & CAO
    Sale
    $141K 1,913 shares at $73.57 4.8% of stake
    Traded Feb 17 Filed Feb 19
  10. Levien Meredith A. Kopit CEO
    Sale
    $1M 16,972 shares at $59.68 14% of stake
    Traded Nov 6, 2025 Filed Nov 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 65 stock grants, 30 share withholdings for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 5.02
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.